z-logo
Premium
Aflibercept improves outcome in eyes with poor vision from neovascular age‐related macular degeneration
Author(s) -
TomkinsNetzer Oren,
SeguinGreenstein Sophie,
Woronkowicz Malgorzata,
Lightman Sue
Publication year - 2017
Publication title -
acta ophthalmologica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.534
H-Index - 87
eISSN - 1755-3768
pISSN - 1755-375X
DOI - 10.1111/aos.13251
Subject(s) - aflibercept , ranibizumab , medicine , macular degeneration , pro re nata , ophthalmology , visual acuity , bevacizumab , surgery , chemotherapy

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom